| Intrance Medical Systems Inc.. (9/20/21). "Press Release: Intrance Medical Systems Raises $8 Million to Support Development of Its Innovative Therapy for Advanced Parkinson’s Disease". Stockholm & New York, NY. |
2021-09-20 |
| Forbion Capital Partners. (9/16/21). "Press Release: Forbion Launches Portfolio Company Oxitope Pharma Focused on Inflammatory, Cardiovascular and Fibrotic Diseases". Naarden. |
2021-09-16 |
| Oxitope Pharma B.V.. (9/16/21). "Press Release: Launch of Oxitope Pharma, a Biopharmaceutical Start-up Dedicated to the Discovery and Development of Antibody-based Medicines for the Treatment of Diseases Caused by Oxidative Stress". Amsterdam. |
2021-09-16 |
| Anjarium Biosciences AG. (9/16/21). "Press Release: Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies". Schlieren. |
2021-09-16 |
| Touchlight Genetics Ltd.. (9/15/21). "Press Release: Touchlight Extends Funding Round to US$125M as Demand for Its dbDNA Grows Rapidly". |
2021-09-15 |
| Novo Nordisk Foundation. (9/15/21). "Press Release: Novo Nordisk Foundation and Broad Institute of MIT and Harvard Launch New Research Center for Genomic Mechanisms of Disease". Cambridge, MA & Copenhagen. |
2021-09-15 |
| Abingworth LLP. (9/15/21). "Press Release: Abingworth Strengthens Investment Team with New Appointments in the US and UK". London. |
2021-09-15 |
| Roche. (9/15/21). "Press Release: Roche Opens Access to Pathology Imaging Tools to Improve Patient Care". Basel. |
2021-09-15 |
| Mesa Laboratories, Inc.. (9/14/21). "Press Release: Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.". Lakewood, CO. |
2021-09-14 |
| Nordic Nanovector ASA. (9/14/21). "Press Release: Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer". Oslo. |
2021-09-14 |
| CureVac N.V.. (9/14/21). "Press Release: CureVac Streamlines European Network for mRNA Product Manufacturing". Tübingen & Boston, MA. |
2021-09-14 |
| TreeFrog Therapeutics S.A.S.. (9/13/21). "Press Release: TreeFrog Therapeutics Secures $75M in Series B Financing to Advance a Pipeline of Stem Cell-derived Cell therapies and Deploy Proprietary C-Stem Technology in the USA & Japan". Bordeaux. |
2021-09-13 |
| Twist Bioscience Corporation. (9/9/21). "Press Release: Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration". South San Francisco, CA & Ingelheim. |
2021-09-09 |
| Twist Bioscience Corporation. (9/9/21). "Press Release: Twist Bioscience to Present at Baird 2021 Global Healthcare Conference". South San Francisco, CA & Ingelheim. |
2021-09-09 |
| Roche. (9/9/21). "Press Release: Roche Signs Definitive Share Purchase Agreement with Long-Term Partner TIB Molbiol to Expand PCR-test Portfolio in the Fight against New Infectious Diseases". Basel. |
2021-09-09 |
| Exscientia Ltd.. (9/8/21). "Press Release: Exscientia Enters $70M Collaboration to Develop Anti-viral Therapeutics against Coronavirus and other Viruses with Pandemic Potential". |
2021-09-08 |
| Owlstone Medical Ltd.. (9/7/21). "Press Release: Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy". Cambridge. |
2021-09-07 |
| EnteroBiotix Ltd.. (9/7/21). "Press Release: EnteroBiotix Raises over $21m in Series A Financing to Advance its Microbiome Drug Pipeline". Glasgow. |
2021-09-07 |
| Argenx SE. (9/3/21). "Press Release: Argenx to Present at Upcoming Investor Conferences". Breda. |
2021-09-03 |
| Moderna, Inc.. (9/3/21). "Press Release: Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster". Cambridge, MA. |
2021-09-03 |
| Moderna, Inc.. (9/2/21). "Press Release: Moderna to Present at Upcoming Investor Conferences in September 2021". Cambridge, MA. |
2021-09-02 |
| Fluidigm Corporation. (9/2/21). "Press Release: Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference". South San Francisco, CA. |
2021-09-02 |
| Ionis Pharmaceuticals, Inc.. (9/2/21). "Press Release: Ionis to Present at Upcoming Virtual Investor Conferences". Carlsbad, CA. |
2021-09-02 |
| ImmunOs Therapeutics AG. (9/1/21). "Press Release: ImmunOs Therapeutics Appoints Jeffrey Abbey as Chief Operating Officer, Establishes Clinical Advisory Board". Schlieren. |
2021-09-01 |
| Ascendis Pharma A/S. (8/31/21). "Press Release: Ascendis Pharma A/S Announces Proposed Public Offering of ADSs". Copenhagen. |
2021-08-31 |
| Tissium S.A.. (8/31/21). "Press Release: Tissium Raises €50M in Series C Financing to Propel Its Platform to Commercial Stage". Paris. |
2021-08-31 |
| Galapagos N.V.. (8/30/21). "Press Release: Galapagos Announces Planned Retirement of CEO". Mechelen. |
2021-08-30 |
| Fresenius Medical Care AG & Co. KGaA. (8/30/21). "Press Release: Fresenius Medical Care Increases Investment in Humacyte, Accompanies Human Acellular Vessel Developer’s Stock Market Launch". |
2021-08-30 |
| Laronde. (8/30/21). "Press Release: Laronde Attracts $440M in First External Financing to Further Advance Endless RNA Platform". Cambridge, MA. |
2021-08-30 |
| Lynk Pharmaceuticals Co., Ltd.. (8/27/21). "Press Release: Lynk Pharmaceuticals Announced the Completion of Series B Financing of $50 million". Hangzhou. |
2021-08-27 |
| MorphoSys AG. (8/26/21). "Press Release: MorphoSys and Incyte Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma". Plan |
2021-08-26 |
| ADC Therapeutics S.A.. (8/26/21). "Press Release: ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million". Lausanne. |
2021-08-26 |
| Humacyte, Inc.. (8/26/21). "Press Release: Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.". Durham, NC. |
2021-08-26 |
| Cardior Pharmaceuticals GmbH. (8/25/21). "Press Release: Cardior Raises €64 M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease". Hanover. |
2021-08-25 |
| Ori Biotech Ltd.. (8/25/21). "Press Release: Ori Biotech Expands Board of Directors and Scientific Advisory Board". London. |
2021-08-25 |
| MorphoSys AG. (8/24/21). "Press Release: Health Canada Grants Marketing Authorization for Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma". Planegg. |
2021-08-24 |
| DiCE Molecules SV, Inc.. (8/24/21). "Press Release: DiCE Molecules Announces $60 Million Series C-1 Financing". South San Francisco, CA. |
2021-08-24 |
| Bristol-Myers Squibb Company. (8/19/21). "Press Release: Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma". Princeton, NJ. |
2021-08-19 |
| Zelluna Immunotherapy AS. (8/19/21). "Press Release: Exclusive License Agreement with the U.S. National Cancer Institute to Develop and Commercialize KK-LC-1 Targeting Allogeneic »Off-the-Shelf« TCR Based Natural Killer (TCR-NK) Cell Therapies". Oslo. |
2021-08-19 |
| Immunitas Therapeutics Inc.. (8/18/21). "Press Release: Immunitas Therapeutics Completes $58 Million Series B Financing". Waltham, MA. |
2021-08-18 |
| Vigil Neuroscience, Inc.. (8/18/21). "Press Release: Vigil Neuroscience Completes $90 million Series B Financing to Advance a Pipeline of Microglia-targeted Medicines to Treat Rare and Common Neurodegenerative Diseases". Cambridge, MA. |
2021-08-18 |
| Ranok Therapeutics (Hangzhou) Co., Ltd.. (8/18/21). "Press Release: Ranok Therapeutics Secures $40 Million Series B Financing to Advance its Innovative Targeted Protein Degradation Pipeline". Boston, MA & Hangzhou. |
2021-08-18 |
| Jnana Therapeutics Inc.. (8/18/21). "Press Release: Jnana Therapeutics Closes $50 Million Series B Financing to Advance Lead PKU Program and Small Molecule Pipeline Based on Next Gen Chemoproteomic Platform". Boston, MA. |
2021-08-18 |
| EQRx, Inc.. (8/18/21). "Press Release: EQRx Appoints Richard Buckley as Chief Corporate Affairs Officer". |
2021-08-18 |
| Humacyte, Inc.. (8/17/21). "Press Release: Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs". Durham, NC. |
2021-08-17 |
| MorphoSys AG. (8/17/21). "Press Release: MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China". Planegg. |
2021-08-17 |
| ERS Genomics Ltd.. (8/17/21). "Press Release: ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement". Dublin & Coralville, IA. |
2021-08-17 |
| Lumicks Technologies B.V.. (8/17/21). "Press Release: Lumicks Appoints Paul Wheeler to Leadership Team as Chief Commercial Officer to Drive New Business Growth". Amsterdam. |
2021-08-17 |
| CureVac N.V.. (8/16/21). "Press Release: Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study". Tübingen, Boston, MA & London. |
2021-08-16 |
| CureVac N.V.. (8/16/21). "Press Release: CureVac Announces Financial Results for the Second Quarter and First Half of 2021 and Provides Business Update". Tübingen, Boston, MA & London. |
2021-08-16 |
| Ultromics Ltd.. (8/16/21). "Press Release: Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment". Oxford. |
2021-08-16 |
| Opko Health. (8/16/21). "Press Release: BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business". Elmwood Park, NJ. |
2021-08-16 |
| Beckley Psytech Ltd.. (8/15/21). "Press Release: Beckley Psytech Completes Oversubscribed $80m (£58m) Fundraise to Develop Portfolio of Psychedelic Medicine Breakthroughs". Oxford. |
2021-08-15 |
| Berkeley Lights, Inc.. (8/11/21). "Press Release: Berkeley Lights and Bayer Announce a Multi-year Agreement Aimed at Revolutionizing the Discovery of Next-generation Traits". Emeryville, CA. |
2021-08-11 |
| Evotec SE. (8/11/21). "Press Release: Just - Evotec Biologics Opens J.POD 1 US in Redmond, Washington". Hamburg. |
2021-08-11 |
| Visus Therapeutics Inc.. (8/10/21). "Press Release: Visus Therapeutics Secures $20 Million in Additional Financing Led by New Investor LSP, with Participation from Sage Partners". Seattle, WA. |
2021-08-10 |
| MoonLake Immunotherapeutics AG. (8/10/21). "Press Release: MoonLake Immunotherapeutics Appoints Former Kymab CEO Simon Sturge as Chairman and Spike Loy to the Board of Directors". Zug. |
2021-08-10 |
| Mission Therapeutics Ltd.. (8/9/21). "Press Release: Mission and AbbVie Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Next Milestone- Mission Receives $20 Million Milestone payment". Cambridge. |
2021-08-09 |
| Qiagen N.V.. (8/9/21). "Press Release: Qiagen and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements". Hilden, Waltham, MA & Germantown, MD. |
2021-08-09 |
| EQRx, Inc.. (8/6/21). "Press Release: EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III". |
2021-08-06 |
| PepGen, Inc.. (8/5/21). "Press Release: PepGen Announces Closing of $112.5 Million Crossover Financing to Advance Transformative Therapies for Neuromuscular Diseases". Boston, MA. |
2021-08-05 |
| Bayer AG. (8/5/21). "Press Release: Bayer Strengthens Drug Discovery Platform through Acquisition of Vividion Therapeutics". Berlin. |
2021-08-05 |
| Sonoma Biotherapeutics Inc.. (8/4/21). "Press Release: Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the Promise of Cell Therapy into Curative Medicines for Autoimmune and Other Inflammatory Diseases". So |
2021-08-04 |
| Bristol-Myers Squibb Company. (8/3/21). "Press Release: Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland". New York, NY. |
2021-08-03 |
| Sanofi S.A.. (8/3/21). "Press Release: Sanofi to Acquire Translate Bio, Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development". Paris & Lexington, MA. |
2021-08-03 |
| Engrail Therapeutics, Inc.. (8/3/21). "Press Release: Engrail Therapeutics Extends Series A Financing to $64 Million". San Diego, CA. |
2021-08-03 |
| ADC Therapeutics S.A.. (8/3/21). "Press Release: ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates". Lausanne. |
2021-08-03 |
| Pacific Biosciences of California, Inc.. (8/3/21). "Press Release: Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results". Menlo Park, CA. |
2021-08-03 |
| Pacific Biosciences of California, Inc.. (8/3/21). "Press Release: Pacific Biosciences Acquires Circulomics – a Leading High Molecular Weight DNA Extraction Company". Menlo Park, CA. |
2021-08-03 |
| Mestag Therapeutics Ltd.. (8/3/21). "Press Release: Mestag Therapeutics Extends Seed Financing to $45 Million and Welcomes New Investors Forbion, GV (formerly Google Ventures) and Northpond Ventures". Cambridge. |
2021-08-03 |
| Synthace Ltd.. (8/2/21). "Press Release: Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists". London. |
2021-08-02 |
| Evotec SE. (8/2/21). "Press Release: Evotec SE Announces Confidential Submission of Draft Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission for a Proposed Offering of American Depositary Shares (Ad hoc". Hamburg. |
2021-08-02 |
| Abcam plc. (8/2/21). "Press Release: Abcam to Acquire BioVision for $340 Million". Cambridge. |
2021-08-02 |
| T-Knife Therapeutics, Inc.. (8/2/21). "Press Release: T-Knife Therapeutics Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies". San Francisco, CA & Berlin. |
2021-08-02 |
| Landmark Bio PPLLC. (7/29/21). "Press Release: Introducing Landmark Bio and Appointment of Ran Zheng as CEO". Watertown, MA. |
2021-07-29 |
| Valneva S.E.. (7/29/21). "Press Release: Valneva Appoints Peter Buhler as Chief Financial Officer". Saint-Herblain. |
2021-07-29 |
| Novacyt S.A.. (7/29/21). "Press Release: David Allmond Announced as CEO Following Decision by Graham Mullis to Retire". Paris & Camberley. |
2021-07-29 |
| Atai Life Sciences N.V.. (7/28/21). "Press Release: Atai Life Sciences Launches InnarisBio, in Partnership with the University of Queensland". Berlin & Brisbane. |
2021-07-28 |
| Artios Pharma Ltd.. (7/27/21). "Press Release: Artios Announces $153 Million (£110 Million) Series C Financing Led by Omega Funds and TCG X". Cambridge & New York, NY. |
2021-07-27 |
| SynOx Therapeutics Ltd.. (7/27/21). "Press Release: SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer". Dublin. |
2021-07-27 |
| BlueRock Therapeutics LP. (7/26/21). "Press Release: BlueRock Therapeutics Announces New Board Chair, New President and CEO". Cambridge, MA. |
2021-07-26 |
| AXA Investment Managers. (7/26/21). "Press Release: AXA IM Alts Raises €1.9 Billion for European Life Sciences Investments". |
2021-07-26 |
| Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge. |
2021-07-26 |
| Lumira Ventures. (7/26/21). "Press Release: Lumira Ventures Closes on US$255 Million of New Capital to Build Transformative Healthcare Companies". Toronto, Montreal, Vancouver & Boston. |
2021-07-26 |
| Bayer AG. (7/26/21). "Press Release: Bayer Announces Prof. Dr. Dominik Ruettinger as New Head of Research and Early Development for Oncology". Berlin. |
2021-07-26 |
| PerkinElmer, Inc.. (7/26/21). "Press Release: PerkinElmer to Acquire Antibody and Reagent Leader BioLegend". Waltham, MA. |
2021-07-26 |
| Relief Therapeutics Holding AG. (7/26/21). "Press Release: Relief Therapeutics Announces CHF 15 Million Private Placement (Ad Hoc)". Geneva. |
2021-07-26 |
| Abivax S.A.. (7/23/21). "Press Release: Abivax Announces the Pricing of Its Oversubscribed Capital Increase of EUR 60M and Convertible Bonds of EUR 25M, Totaling EUR 85M New Financing". Paris. |
2021-07-23 |
| Sophia Genetics S.A.. (7/22/21). "Press Release: Sophia Genetics Announces Pricing of Initial Public Offering". Boston, MA & Lausanne. |
2021-07-22 |
| Synaffix B.V.. (7/22/21). "Press Release: Synaffix Announces Deal with ProfoundBio Worth up to $246 Million Providing Access to Multiple Novel Linker-Payload Technologies". Amsterdam. |
2021-07-22 |
| EMBL. (7/22/21). "Press Release: DeepMind and EMBL Release the Most Complete Database of Predicted 3D Structures of Human Proteins". London. |
2021-07-22 |
| Slingshot Biosciences. (7/22/21). "Press Release: Slingshot Biosciences Announces $23 Million in Series A Financing". Emeryville, CA. |
2021-07-22 |
| Excellims Corporation. (7/21/21). "Press Release: Fast, Efficient High Performance Ion Mobility Spectrometry Proves a Compelling PAT for Pharma". Acton, MA. |
2021-07-21 |
| Berkeley Lights, Inc.. (7/21/21). "Press Release: Berkeley Lights Announces Technology Collaboration to Accelerate and Improve Gene Therapy Viral Vector Development and Manufacturing". Emeryville, CA. |
2021-07-21 |
| Pacific Biosciences of California, Inc.. (7/20/21). "Press Release: Pacific Biosciences and Invitae Announce Intent to Expand Collaboration". Menlo Park, CA. |
2021-07-20 |
| XPhyto Therapeutics Corporation. (7/20/21). "Press Release: XPhyto Signs Transformative Acquisition Agreement with 3a-Diagnostics, to Enter Hi-tech Biosensor Market and Expand Its Diagnostic Product Portfolio". Vancouver, BC & Frankfurt. |
2021-07-20 |
| Pacific Biosciences of California, Inc.. (7/20/21). "Press Release: Pacific Biosciences Signs Definitive Agreement to Acquire Omniome". Menlo Park, CA & San Diego, CA. |
2021-07-20 |
| Element Biosciences, Inc.. (7/20/21). "Press Release: Element Biosciences Bolsters Leadership Team to Advance Development and Commercialization of DNA Sequencing Platform". San Diego, CA. |
2021-07-20 |
| BioNTech SE. (7/19/21). "Press Release: BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD". Mainz & Santo Monica, CA. |
2021-07-19 |
| BlueRock Therapeutics LP. (7/19/21). "Press Release: BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson’s Disease". Cambridge, MA. |
2021-07-19 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2019.png){kind=logo}
Date![Picture [iito] Fighting Customers 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-fighting-customers.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
